4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-17-023165
Director acquired 778 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Thomas E. Director | 2017-03-24 | Grant or award | +778 | 14,840 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Thomas E. Director | 2017-03-24 | Grant or award · Stock Option (right to buy) | +1,191 | 1,191 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…